Results 161 to 170 of about 5,099,009 (221)

Extracorporeal Cytokine Hemadsorption for the Treatment of Severe Steroid Refractory Cytokine Release Syndrome Secondary to T-Cell Immunotherapy for B-Cell Malignancies: A Case Series. [PDF]

Hematol Oncol
Cavallaro G, Ferrari S, Pollastri A, Di Credico E, Meli C, Rondi M, Putelli A, Lussana F, Grassi A, Rambaldi A, Valetti TM, Riva I, Gritti G.   +12 more
europepmc   +1 more source

Case Report: A rare case of primary graft failure after autologous stem cell transplant for mantle cell lymphoma rescued with darbepoetin, eltrombopag, and cyclosporine. [PDF]

Front Transplant
Ly SH, Hwang JCC, Woon YK, Nargarajan C, Quek JKS, Linn YC, Tuy TT.   +6 more
europepmc   +1 more source

Patient Perspectives on Non-Hodgkin Lymphoma: A Qualitative Study to Guide Selection of Clinical Trial Endpoints. [PDF]

Curr Oncol
Clark A, Tomme SV, Hetherington L, Barbosa CD, Cordero P.   +4 more
europepmc   +1 more source

Correction: A novel immune model predicts the prognosis of mantle cell lymphoma. [PDF]

Front Med (Lausanne)
Hao X, Zhang Y, Qi W, Zhu M, Wang J, Yang P, Zhang W, Jing H.   +7 more
europepmc   +1 more source

In mantle cell lymphoma, whether 18 F-FDG PET/CT or flow cytometry provide superior diagnostic performance compared to biopsy in the determination of bone marrow involvement and enhance prognostic predictive value. [PDF]

Ann Hematol
Wang D, Wu H, Li M, Sun J, Xie Z, Zhang M, Zhang L, Chang Y.   +7 more
europepmc   +1 more source

Beyond the Nodes: Atypical Presentations of Non-Hodgkin's Lymphoma Across Organs. [PDF]

Cureus
A S, D'Cruze L, Archana B, Sundaram S, Priyathersini N.   +4 more
europepmc   +1 more source

Central nervous system involvement in mantle cell lymphoma: clinical features, prognostic factors and outcomes from the European Mantle Cell Lymphoma Network†

Annals of Oncology, 2013
Central nervous system (CNS) involvement in mantle cell lymphoma (MCL) is uncommon, and the manifestations and natural history are not well described.We present the data on 57 patients with MCL who developed CNS involvement, from a database of 1396 ...
Pavel Klener, Annalisa Chiappella, Lukáš Smolej   +2 more
exaly   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

Mantle cell lymphoma

Critical Reviews in Oncology/Hematology, 2012
MCL is a well-characterized clinically aggressive lymphoma with a poor prognosis. Recent research findings have slightly improved the outcome of this neoplasm. The addition of rituximab to conventional chemotherapy has increased overall response rates, but it does not improve overall survival with respect to chemotherapy alone.
Cortelazzo S, PONZONI , MAURILIO, Ferreri AJM, Dreyling M.   +3 more
openaire   +5 more sources